Darwin Global Management, Ltd. Relay Therapeutics, Inc. Transaction History

Darwin Global Management, Ltd.

  • $827 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$29.75 - $37.99 $3.56 Million - $4.55 Million
-119,775 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$27.5 - $38.19 $18.2 Million - $25.3 Million
-662,696 Reduced 84.69%
119,775 $4.38 Million
Q1 2021

May 17, 2021
BUY
$32.52 - $61.53 $25.4 Million - $48.1 Million
782,471 New
782,471 $27.1 Million

Others Institutions Holding RLAY

# of Institutions
181
Shares Held
127M
Call Options Held
16.7K
Put Options Held
18K
View Full List

About Relay Therapeutics, Inc.

RLAY Quotes by TradingView
  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $702M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Darwin Global Management, Ltd. Portfolio

Follow Darwin Global Management, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Global Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Darwin Global Management, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email